Total Payments
$367,581
2024 Payments
$68,008
Companies
49
Transactions
1,053
Medicare Patients
6,380
Medicare Billing
$934,074
Payment Breakdown by Category
Other$279,421 (76.0%)
Travel$52,377 (14.2%)
Food & Beverage$33,337 (9.1%)
Consulting$2,400 (0.7%)
Education$46.85 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $279,421 | 115 | 76.0% |
| Travel and Lodging | $52,377 | 182 | 14.2% |
| Food and Beverage | $33,337 | 751 | 9.1% |
| Consulting Fee | $2,400 | 1 | 0.7% |
| Education | $46.85 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $140,334 | 269 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $48,859 | 64 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $46,639 | 90 | $0 (2024) |
| Esperion Therapeutics, Inc. | $44,465 | 73 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $40,851 | 38 | $0 (2019) |
| Boston Scientific Corporation | $16,427 | 98 | $0 (2024) |
| Amarin Pharma Inc. | $9,837 | 21 | $0 (2021) |
| Medtronic Vascular, Inc. | $5,067 | 59 | $0 (2020) |
| Abbott Laboratories | $3,675 | 61 | $0 (2024) |
| ABIOMED | $2,108 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,008 | 200 | Amgen Inc. ($56,423) |
| 2023 | $58,661 | 159 | Amgen Inc. ($54,694) |
| 2022 | $36,867 | 115 | Amgen Inc. ($14,177) |
| 2021 | $37,837 | 103 | Esperion Therapeutics, Inc. ($23,903) |
| 2020 | $15,340 | 66 | Amarin Pharma Inc. ($9,641) |
| 2019 | $50,021 | 129 | SANOFI-AVENTIS U.S. LLC ($22,868) |
| 2018 | $59,274 | 147 | Regeneron Healthcare Solutions, Inc. ($29,790) |
| 2017 | $41,573 | 134 | SANOFI-AVENTIS U.S. LLC ($14,787) |
All Payment Transactions
1,053 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/06/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $59.22 | General |
| Category: Structural Heart | ||||||
| 12/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $42.23 | General |
| Category: Cardiovascular Device | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | In-kind items and services | $1,173.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: EMBLEM_CRM | ||||||
| 11/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $85.93 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $336.48 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $111.41 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $85.76 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,683 | 4,076 | $638,385 | $275,598 |
| 2022 | 22 | 1,791 | 4,091 | $566,992 | $273,655 |
| 2021 | 22 | 1,533 | 3,430 | $442,228 | $215,936 |
| 2020 | 23 | 1,373 | 3,208 | $422,761 | $168,885 |
Total Patients
6,380
Total Services
14,805
Medicare Billing
$934,074
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 630 | 2,055 | $439,866 | $209,082 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $19,698 | $8,719 | 44.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 38 | 38 | $21,584 | $7,691 | 35.6% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 38 | 310 | $16,120 | $6,451 | 40.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 77 | 243 | $18,118 | $5,545 | 30.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 274 | $11,716 | $5,524 | 47.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $13,908 | $4,849 | 34.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 44 | 153 | $20,808 | $4,583 | 22.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 59 | 75 | $10,200 | $4,551 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 42 | $7,713 | $2,927 | 37.9% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 22 | 32 | $5,696 | $2,517 | 44.2% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 146 | 156 | $10,959 | $2,429 | 22.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 145 | 155 | $10,039 | $2,188 | 21.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 14 | 90 | $5,400 | $1,905 | 35.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $3,250 | $1,821 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 129 | 152 | $12,312 | $1,810 | 14.7% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 61 | 66 | $4,488 | $1,214 | 27.0% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 17 | 18 | $2,052 | $974.63 | 47.5% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 61 | 66 | $2,838 | $469.97 | 16.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 34 | 35 | $1,620 | $348.60 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 600 | 1,805 | $335,730 | $190,295 | 56.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $22,458 | $10,291 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 172 | $20,984 | $9,520 | 45.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 50 | 53 | $22,260 | $8,747 | 39.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 33 | 33 | $18,744 | $6,992 | 37.3% |
About Dr. Samir Bhatt, MD
Dr. Samir Bhatt, MD is a Cardiovascular Disease healthcare provider based in Santa Maria, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295925972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samir Bhatt, MD has received a total of $367,581 in payments from pharmaceutical and medical device companies, with $68,008 received in 2024. These payments were reported across 1,053 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($279,421).
As a Medicare-enrolled provider, Bhatt has provided services to 6,380 Medicare beneficiaries, totaling 14,805 services with total Medicare billing of $934,074. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Santa Maria, CA
- Active Since 07/27/2007
- Last Updated 09/25/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1295925972
Products in Payments
- Repatha (Biological) $140,185
- XARELTO (Drug) $46,648
- NEXLIZET (Drug) $41,963
- PRALUENT (Drug) $40,851
- PRALUENT ALIROCUMAB INJECTION (Biological) $38,155
- PRALUENT (Biological) $10,552
- Vascepa (Drug) $9,837
- WATCHMAN Access System (Device) $9,247
- WATCHMAN (Device) $2,995
- NEXLETOL (Drug) $2,503
- Resolute (Device) $2,224
- Impella (Device) $2,108
- THERAPIES (Device) $1,397
- Reveal LINQ (Device) $1,184
- JARDIANCE (Drug) $1,010
- Optimizer (Device) $650.81
- ENTRESTO (Drug) $572.87
- MitraClip System (Device) $495.29
- ASAHI PTCA Guide Wire (Device) $429.16
- GALLANT (Device) $426.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Santa Maria
Keith Somma, M.d, M.D
Cardiovascular Disease — Payments: $25,303
Cardiovascular Disease $25,303
Alex Harrison, Md, MD
Cardiovascular Disease — Payments: $14,195
Cardiovascular Disease $14,195
Dr. Mark Ginkel, Md, MD
Cardiovascular Disease — Payments: $8,802
Cardiovascular Disease $8,802
Dr. Jason Choi, Md, MD
Cardiovascular Disease — Payments: $4,984
Cardiovascular Disease $4,984
Rikin Tank, M.d, M.D
Cardiovascular Disease — Payments: $2,419
Cardiovascular Disease $2,419
Dr. Ramachandra Setty, Md, MD
Cardiovascular Disease
Cardiovascular Disease